Cerecor Reports Third Quarter 2018 Results
BALTIMORE, Nov. 13, 2018 (GLOBE NEWSWIRE) — Cerecor Inc. (“Cerecor” or the “Company”) (NASDAQ: CERC), a fully integrated biopharmaceutical company […]
Valeritas Signs Exclusive Middle East Distribution Agreement with Julphar
– V-Go distribution deals now span 14 countries and territories – BRIDGEWATER, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) — Valeritas […]
Albireo Reports Third Quarter 2018 Financial Results
Odevixibat selected as International Nonproprietary Name (INN) for A4250 A4250 granted Fast Track and additional Orphan Drug designations A4250 Phase […]
EyeGate Pharma Announces Positive Results in Punctate Epitheliopathy Study
WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study […]
National Vision Holdings, Inc. Reports Third Quarter 2018 Financial Results
Net revenue increased 11.9% to $387.4 million Comparable store sales growth of 7.0%; Adjusted comparable store sales growth of 6.8% […]
EyeGate Pharma Announces Positive Results in Second PRK Study
Data confirms results from earlier study WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today […]
Superconductor Technologies Reports Third Quarter 2018 Results
AUSTIN, Texas, Nov. 13, 2018 (GLOBE NEWSWIRE) — Superconductor Technologies Inc. (STI) (Nasdaq: SCON) reported financial results for the three […]
InvaGen (a Cipla subsidiary) Announces Acquisition Agreement with Avenue Therapeutics for Specialty Hospital Business in the U.S.
Upon first stage closing, InvaGen Pharmaceuticals Inc., a Cipla subsidiary (“InvaGen”), to acquire shares representing a 33.3% stake in Avenue […]
Jounce Therapeutics Reports Third Quarter 2018 Financial Results
– Dose escalation cohorts of JTX-2011 Phase 1/2 ICONIC trial, in combination with ipilimumab and in combination with pembrolizumab, on […]
Eyenovia Reports Third Quarter 2018 Financial Results
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology […]
